Wedbush Reiterates Bullish Stance on Relypsa (RLYP) Following Veltassa MoM Acceleration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
BTIG Trims Q1 Sales Outlook on Relypsa's (RLYP) Veltassa Following Recent Update; Affirms at 'Buy'
April 15, 2016 2:44 PM EDTBTIG affirms Relypsa, Inc. (Nasdaq: RLYP) with a Buy rating and $45 price target after the company disclosed new patient starts, outpatient prescriptions and... More
Mizuho Weighs in on Relypsa (RLYP) Veltassa Numbers and Latest on M&A
April 15, 2016 9:59 AM EDTMizuho Securities analyst Irina Koffler weighed in on Relypsa, Inc. (NASDAQ: RLYP) following today's Veltassa prescriptions numbers and the latest M&A speculation.
Koffler noted that Veltassa prescriptions sold were in-line with their estimates. "Relypsa released March's Veltassa numbers, and reported 1,277 patients received a free starter supply of Veltassa, 706 retail prescriptions were filled, and 201 hospital packs were sold. In all, a total of 907 prescriptions/units were reimbursed. This compares to our estimates of 1,624 patients receiving the starter kit, 700 retail TRx's... More
Relypsa (RLYP) Veltassa Numbers for Outpatient and Hospitals Surge in March
April 15, 2016 8:36 AM EDTRelypsa (NASDAQ: RLYP) disclosed in an SEC filing.
Relypsa, Inc. (the Company) discloses herein the new patient starts, outpatient prescriptions and units sold to hospitals/other institutions for the full month... More
Relypsa (RLYP) Has Multiple Banking Relationships
April 15, 2016 7:48 AM EDTRelypsa, Inc. (NASDAQ: RLYP) is trading sharply lower (-13.9%) in pre-open trade Friday as questions emerge about which investment bank the company is working with to field potential offers. Overnight, a report from... More
